Aspirin–hydrogel ocular film for topical delivery and ophthalmic anti-inflammation Scientific paper

Main Article Content

Ashirbad Nanda
https://orcid.org/0000-0002-9820-0208
Shubhashree Das
https://orcid.org/0000-0002-7747-3514
Rudra N. Sahoo
https://orcid.org/0000-0001-6348-950X
Souvik Nandi
https://orcid.org/0000-0003-4371-3345
Rakesh Swain
https://orcid.org/0000-0003-1907-1653
Sunil Pattanaik
https://orcid.org/0000-0003-4681-5590
Debajyoti Das
Subrata Mallick
https://orcid.org/0000-0002-6606-1223

Abstract

Ocular drug delivery in hydrogel forming film form has several bene­fits over conventional dosage forms. An ophthalmic anti-inflammation study was undertaken using topically applied aspirin in a hydrogel film for­mulation. A hydroxypropyl methylcellulose (HPMC) matrix film formulation was pre­pared by the solvent casting and evaporation technique by taking triethanol­amine (TEA) as a plasticizer. Ex vivo corneal permeation as well as anti-inf­lam­matory potential of aspirin was studied on carrageenan induced rab­bit eye model. Moisture uptake was found to be in the range of 17.1 and 19.1 % for all the film formulations. The film with the higher HPMC content exhibited both increased moisture uptake and amount of swelling. Among the formul­ations, the swelling order was found to increase with increasing amount of HPMC in the film. Presence of the hydrogel matrix forming polymer sustained the drug release and corneal permeation for more than 6 h and controlled the process by the diffusion mechanism. The signs of carrageenan induced acute inflammation was inhibited completely within just 2 h of placing the film in the rabbit eye whilst the positive control continued showing redness and increased tear sec­retion. Aspirin ocular film formulation could be utilized for ocular anti-inflam­mation for an extended period of time with better patient compliance.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Article Details

How to Cite
[1]
A. . Nanda, “Aspirin–hydrogel ocular film for topical delivery and ophthalmic anti-inflammation: Scientific paper”, J. Serb. Chem. Soc., vol. 87, no. 7-8, pp. 829–843, Apr. 2022.
Section
Organic Chemistry

References

G. Fang, Q. Wang, X. Yang, Y. Qian, G. Zhang, Q. Zhu, B. Tang, Colloids Surfaces,. A 627 (2021) 127187 (https://doi.org/10.1016/j.colsurfa.2021.127187)

G. Fan, G. Li-li, W. Yan-rong, Q.I. Wang, Int. Eye Sci. 17 (2017) 2359 (https://doi.org/10.3980/j.issn.1672-5123.2017.12.45)

M. T. Kralinger, M. Voigt, G. F. Kieselbach, D. Hamasaki, B. C. Hayden, J. M. Parel, Ophthalmic Res. 35 (2003) 102 (https://doi.org/10.1159/000069129)

S. Das, J. R. Bellare, R. Banerjee, Colloids Surfaces, B 93 (2012) 161 (https://doi.org/10.1016/j.colsurfb.2011.12.033)

A. Yazici, E. Sarı, E. Ayhan, J. Ocul. Pharmacol. Ther. 34 (2018) 256 (https://doi.org/10.1089/jop.2017.0064)

Ameeduzzafar, J. Ali, M. Fazil, M. Qumbar, N. Khan, A. Ali, Drug Deliv. 23 (2016) 700 (https://doi.org/10.3109/10717544.2014.923065)

L. Battaglia, M. Gallarate, L. Serpe, F. Foglietta, E. Muntoni, A. P. Rodriguez, M. Angeles, S. Aspiazu, in Lipid Nanocarriers for Drug Targeting, A. M. Grumezescu, Ed., William Andrew Applied Science Publishers, Norwich, NY, 2018, pp. 269–312 (https://doi.org/10.1016/B978-0-12-813687-4.00007-4)

A. Pramanik, R. N. Sahoo, S. K. Pradhan, S. Mallick, Indian J. Pharm. Sci. 83 (2021) 794-807 (https://doi.org/10.36468/pharmaceutical-sciences.831)

R. Swain, S. Nandi, R. N. Sahoo, S. S. Swain, S. Mohapatra, S. Mallick. J. Drug Deliv. Sci. Technol. 67 (2021) 102956 (https://doi.org/10.1016/j.jddst.2021.102956)

Z. Jafariazar, N. Jamalinia, F. Ghorbani-Bidkorbeh, S. A. Mortazavi, Iran. J. Pharm. Sci. 14 (2015) 23 (https://doi.org/10.22037/ijpr.2015.1709)

G. Fang, X. Yang, Q. Wang, A. Zhang, B. Tang, Mater. Sci. Eng., C 127 (2021) 112212 (https://doi.org/10.1016/j.msec.2021.112212)

N. Kavanagh, O. I. Corrigan, Int. J. Pharm. 279 (2004) 141 (https://doi.org/10.1016/j.ijpharm.2004.04.016)

B. Vigani, S. Rossi, G. Sandri, M. C. Bonferoni, C. M. Caramella, F. Ferrari, Pharmaceutics 12 (2020) 859 (https://doi.org/10.3390/pharmaceutics1209085)

A. A. El-Bary, H. K. Ibrahim, B. S. Haza’a, I. A. Sharabi, Pharm. Dev. Technol. 24 (2019) 824 (https://doi.org/10.1080/10837450.2019.1602631)

M. Mansour, S. Mansour, N. D. Mortada, S. S. Abd El-Hady, Drug. Dev. Ind. Pharm. 34 (2008):744 (https://doi.org/10.1080/03639040801926030)

M. Tighsazzadeh, J. C. Mitchell, J. S. Boateng, Int. J. Pharm. 566 (2019) 111 (https://doi.org/10.1016/j.ijpharm.2019.05.059).

J. Ye, H. Zhang, H. Wu, C. Wang, X. Shi, J. Xie, J. He, J. Yang, Graefes Arch. Clin. 250 (2012) 1459 (https://doi.org/10.1007/s00417-012-2087-4)

A. Nanda, R. N. Sahoo, A. Pramanik, Colloids Surfaces, B 172 (2018) 555 (https://doi.org/10.1016/j.colsurfb.2018.09.011)

M. R. Abbaspour, B. S. Makhmalzadeh, S. Jalali, Jundishapur J. Nat. Pharm. Prod. 5 (2010) 6 (https://brief.land/jjnpp/articles/72379.html)

P. Talik, J. Piotrowska, U. Hubicka, AAPS Pharm. Sci. Tech. 20 (2019) 187 (https://doi.org/10.1208/s12249-019-1406-z)

R. Mohapatra, S. Senapati, C. Sahoo, S. Mallick, Colloids Surfaces, B 123 (2014)170 (https://doi.org/10.1016/j.colsurfb.2014.09.012)

A. Pramanik, R. N. Sahoo, A. Nanda, Curr. Eye Res. 43 (2018) 828 (https://doi.org/10.17344/acsi.2019.5139)

K. N. Priya, S. Bhattacharyya, P. R. Babu, Dhaka Univ. J. Pharm. Sci. 13 (2014) 75 (https://doi.org/10.3329/dujps.v13i1.21866)

B. Panda, R. Subhadarsini, S. Mallick, Expert Opin. Drug Deliv. 13 (2016) 633 (https://doi.org/10.1517/17425247.2016.1154038)

M. J. Habib, J. A. Rogers, Int. J. Pharm. 44 (1988) 235 (https://doi.org/10.1016/0378-5173(88)90120-2)

J. T. Mitchell-Koch, K. R. Reid, M. E. Meyerhoff, J. Chem. Educ. 85 (2008) 1658 (https://doi.org/10.1021/ed085p1658)

N. A. Farid, G. S. Born, W. V. Kessler, S. M. Shaw, W. E. Lange, Clin. Chem. 21 (1975) 1167 (https://doi.org/10.1093/clinchem/21.8.1167)

W. J. Keller Jr., Am. J. Clin. Pathol. 17 (1947) 415 (https://doi.org/10.1093/ajcp/17.5_ts.415)

W. A. McBryde, J. L. Rohr, J. S. Penciner, J. A. Page, Can. J. Chem. 48 (1970) 2574 (https://doi.org/10.1139/v70-433)

A. Pramanik, R. N. Sahoo, S. Nandi, A. Nanda, S. Mallick, Acta Chim. Slov. 68 (2021) 159-69 (http://dx.doi.org/10.17344/acsi.2020.6298)

P. W. Morrison, C. J. Connon, V. V. Khutoryanskiy, Mol. Pharm. 10 (2013) 756 (https://doi.org/10.1021/mp3005963)

R. N. Sahoo, B. S. Satapathy, S. Mallick, J. Serb. Chem. Soc. 86 (2021) 571 (https://doi.org/10.2298/JSC201209021N)

B. S. Satapathy, A. Patel, R. N. Sahoo, S. Mallick, J. Serb. Chem. Soc. 86 (2021) 51 (https://doi.org/10.2298/JSC200705049S)

P. K. Pawar, D. K. Majumdar, AAPS Pharm. Sci. Tech. 7 (2006) 13 (https://doi.org/10.1208/pt070113)

M. F. Sohail, G. Shahnaz, F. ur Rehman, A. ur Rehman, N. Ullah, U. Amin, G. M. Khan, K. U. Shah, AAPS Pharm. Sci. Tech. 20 (2019) 288 (https://doi.org/10.1208/s12249-019-1484-y)

S. Nandi, A. Ojha, A. Nanda, R. N. Sahoo, R. Swain, K. P. Pattnaik, S. Mallick, Z. Phys. Chem. 236 (2021) 275 (https://doi.org/10.1515/zpch-2021-3081)

E. Larraneta, R. E. Lutton, A. J. Brady, E. M. Vicente‐Pérez, A. D. Woolfson, R. R. Thakur, R.F. Donnelly, Macromol. Mater. Eng. 300 (2015) 586 (https://doi.org/10.1002/mame.201500016)

A. Semalty, M. Semalty, D. Singh, M. S. Rawat, Int. J. Pharm. Sci. Nanotechnol. 3 (2010) 940 (https://doi.org/10.37285/ijpsn.2010.3.2.7)

S. Farias, J. S. Boateng, Int. J. Pharm. 553 (2018) 65 (https://doi.org/10.1016/j.ijpharm.2018.10.025)

R. Mohanty, S. K. Das, N. R. Singh, M. Patri, Zebrafish. 13 (2016) 188 (https://doi.org/10.1089/zeb.2015.1215)

J. A. Castro-Hermida, H. GóMez-Couso, M. E. Ares-Mazás, M. M. Gonzalez-Bedia, N. CastañEda-Cancio, F. J. Otero-Espinar, J. Blanco-Mendez, J. Pharm. Sci. 93 (2004) 197 (https://doi.org/10.1002/jps.10528)

T. Oka, T. Shearer, M. Azuma, Curr. Eye Res. 29 (2004) 27 (https://doi.org/10.1080/02713680490513164)

J. C. Fehrenbacher, M. R. Vasko, D. B. Duarte, Curr. Protoc. Pharmacol. 56 (2012) 541 (https://doi.org/10.1002/0471141755.ph0504s56).